The latest price target for TrueBlue (NYSE:TBI) was reported by BMO Capital on November 5, 2025. The analyst firm set a price target for $6.00 expecting TBI to rise to within 12 months (a possible 41.51% upside). 2 analyst firms have reported ratings in the last year.

The latest analyst rating for TrueBlue (NYSE:TBI) was provided by BMO Capital, and TrueBlue maintained their outperform rating.

The last upgrade for TrueBlue Inc happened on May 22, 2023 when BMO Capital raised their price target to $20. BMO Capital previously had a market perform for TrueBlue Inc.

There is no last downgrade for TrueBlue.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of TrueBlue, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for TrueBlue was filed on November 5, 2025 so you should expect the next rating to be made available sometime around November 5, 2026.

While ratings are subjective and will change, the latest TrueBlue (TBI) rating was a maintained with a price target of $8.00 to $6.00. The current price TrueBlue (TBI) is trading at is $4.24, which is out of the analyst’s predicted range.